Yoko E. Furuya, <span>MD, MS</span>

Yoko E. Furuya, MD, MS

Infectious Disease (Board Certified)

Biography

Dr. E. Yoko Furuya is the Medical Director of Infection Prevention & Control and Hospital Epidemiology for all campuses of NewYork-Presbyterian Hospital (Columbia and Cornell). She is also the Director of Antimicrobial Stewardship for NewYork-Presbyterian Hospital (Columbia and Cornell). 

Area of Expertise

Please contact the doctor's office to verify that your insurance is accepted.

Education

University of Pennsylvania School of Medicine

MS, Columbia University, Mailman School of Public Health

Residency: Hospital of the University of Pennsylvania

Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Publications

Bernstein DA, Salsgiver E, Simon MS, Greendyke W, Eiras DP, Ito M, Caruso DA, Woodward TM, Perriel OT, Saiman L, Furuya EY, Calfee DP. Understanding Barriers to Optimal Cleaning and Disinfection in Hospitals: A Knowledge, Attitudes, and Practices Survey of Environmental Services Workers. Infect Control Hosp Epidemiol. 2016 Sep 13:1-4. [Epub ahead of print]

Gomez-Simmonds A, Nelson B, Eiras DP, Loo A, Jenkins SG, Whittier S, Calfee DP, Satlin MJ, Kubin CJ, Furuya EY. Combination Regimens for Treatmetn of Carbapenem-Resistant Klebsiella pneumoniae Bloostream Infections. Antimicrob Agents Chemother. 2016 May 23;60(6):3601-7. doi: 10.1128/AAC.03007-15. Print 2016 Jun.

Furuya EY, Dick AW, Herzig CT, Pogorzelska-Maziarz M, Larson EL, Stone PW. Central Line-Associated Bloodstream Infection Reduction and Bundle Compliance in Intensive Care Units: A National Study. Infect Control Hosp Epidemiol. 2016 Jul;37(7):805-10. doi: 10.1017/ice.2016.67. Epub 2016 Apr 7

Edwards JD, Herzig CT, Liu H, Pogorzelska-Maziarz M, Zachariah P, Dick AW, Saiman L, Stone PW, Furuya EY: Central line-associated blood stream infections in pediatric ICUs: Longitudinal trends and compliance with bundle strategies. Am J Infect Control 2015; 43: 489-93.

Vora NM, Kubin CK, Furuya EY: Appropriateness of gram-negative agent use at a tertiary care hospital in the setting of significant antimicrobial resistance. Open Forum Infect Dis 2015. doi: 10.1093/ofid/ofv009

Pogorzelska-Maziarz M, Herzig CT, Larson EL, Furuya EY, Perencevich EN, Stone PW: Implementation of antimicrobial stewardship policies in US hospitals: findings from a national survey. Infect Control Hosp Epidemiol 2015; 36: 261-4.

Nelson BC, Eiras DP, Gomez-Simmonds A, Loo AS, Satlin MJ, Jenkins SG, Whittier S, Calfee DP, Furuya EY, Kubin CJ. Clinical outcomes associated with polymyxin B dose in patients with bloodstream infections due to carbapenem-resistant Gram-negative rods. Antimicrob Agents Chemother. 2015 Nov;59(11):7000-6. doi: 10.1128/AAC.00844-15. Epub 2015 Aug 31

Zachariah P, Furuya EY, Edwards J, Dick A, Liu H, Herzig CT, Pogorzelska-Maziarz M, Stone PW, Saiman L: Compliance with prevention practices and their association with central line-associated bloodstream infections in neonatal intensive care units. Am J Infect Control 2014; 42: 847-851.

Patel SJ, Oliveira AP, Zhou JJ, Alba L, Furuya EY, Weisenberg SA, Jia H, Clock SA, Kubin CJ, Jenkins SG, Schuetz AN, Behta M, Della-Latta P, Whittier S, Rhee K, Saiman L: Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units. Am J Infect Control 2014; 42: 626-631.

Stone PW, Pogorzelska-Maziarz M, Herzig CT, Weiner LM, Furuya EY, Dick A, Larson E: State of infection prevention in US hospitals enrolled in the National Health and Safety Network. Am J Infect Control 2014; 42: 94-99.

Gomez-Simmonds A, Kubin CJ, Furuya EY: Comparison of three severity criteria for Clostridium difficile infection. Infect Control Hosp Epidemiol 2014; 35: 196-199.